Several coding genes were demonstrated as the direct targets of miR–185-5p (41–43), and the results of sequencing and deregulated gene analysis indicated that CCND2 was inhibited in SURC knockdown CRC cells. This evidence concerns the gene CCND2 and colorectal carcinoma.